John R. Horn, PharmD, FCCP and Philip D. Hansten, PharmD
References
1. Kaleagasioglu F, Olcay E. Fq-induced tendinopathy: etiology and preventive measures. Tohoku J Exp Med. 2012;226:251-8.
2. Khaliq Y, Zhanel GG. Fq-associated tendinopathy: a critical review of the literature. Clin Infect Dis. 2003;36:1404-10.
3. Pierfitte C, Royer RJ. Tendon disorder with fluoroquinolones. Therapie. 1996;51:419-20.
4. Wise B, Peloquin C, Choi H, et al. Impact of age, sex, obesity, and steroid use on quinolone-induced tendon disorders. Am J Med. 2012;125:1228.e23-1228.e28.
5. Corrao G, Zambon A, Bertu L, et al. Evidence of tendinitis provoked by fluoroquinolone treatment. A case control study. Drug Safety. 2006;29:889-96.
6. van der Linden PD, Sturkenboom CMM, Herings RMC, et al. Increased risk of Achilles tendon rupture with quinolone antibacterial use, especially in elderly patients taking oral corticosteroids. Arch Intern Med. 2003;163;1801-7.